Skip to main content

Test Price

3,000 AED

✅ Home Collection Available

Chromosomal Microarray 60K with Karyotyping Test in UAE | 3000 AED | DNA Labs UAE

Executive Summary & Core Metrics

Clinical & Operational Guarantee

  • Accuracy: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Microarray (Agilent 60K) & G‑banded Karyotyping.
  • Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
  • Clinical Guidance: Complimentary telephonic post‑test result interpretation by Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403).
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 (all major UAE networks).
  • Regulatory: DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.

Test Overview & Methodology

The Chromosomal Microarray 60K with Karyotyping integrates high‑resolution copy‑number variation (CNV) detection via Agilent 60K microarray with standard G‑banded karyotyping. This dual approach identifies submicroscopic deletions, duplications, and large chromosomal anomalies in one definitive workflow – essential for paediatric developmental delay, prenatal diagnosis, recurrent pregnancy loss, and haematological malignancy screening. The methodology combines DNA microarray analysis (Agilent 60K, ~60 kb resolution) with cell culture karyotyping (GTG banding, 5–10 Mb resolution).

Feature Our Microarray 60K + Karyotype Conventional Karyotype Alone
Resolution ~60 kb CNV detection genome‑wide (Agilent) 5–10 Mb (visible bands only)
Methodology Agilent 60K Array + Cell Culture Karyotyping GTG Banding alone
Turnaround Time 7–9 working days 10–14 days
Clinical Utility Pathogenic CNVs + aneuploidy + balanced rearrangements Aneuploidy & large structural anomalies only

Physician Insight & Safety Protocols

“Chromosomal microarray at 60K resolution is a powerful tool for detecting clinically significant copy‑number variants, yet variants of uncertain significance and incidental findings require careful interpretation within the family and clinical context. Post‑test genetic counselling is essential to ensure informed decision‑making and to avoid unnecessary anxiety. The concurrent karyotype remains indispensable for detecting balanced structural rearrangements.”


— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403)

Advisory Notice

⚠️ Medication Advisory:

Do not discontinue any prescribed medication or modify treatment plans without consulting your supervising physician. Genetic test results alone do not replace clinical judgement.

Patient Exclusion Criteria & Red Flags

  • Active systemic infection (fever >38.5°C) – reschedule collection until afebrile for 24 hours.
  • Current anticoagulant therapy at therapeutic doses (INR >3.0) without prior medical clearance.
  • Known haemoglobin <7 g/dL – venepuncture risk must be assessed.
  • Recent (<4 weeks) bone marrow transplant or blood product transfusion may yield non‑constitutional results.
  • Emergency warning: If the patient experiences acute bleeding, sudden severe headache, chest pain, or loss of consciousness after sample collection, proceed to the nearest emergency department immediately.

Patient FAQ & Clinical Guidance

1. What conditions can Chromosomal Microarray 60K with Karyotyping detect that a routine karyotype might miss?

Chromosomal microarray (CMA) at 60‑kilobase resolution detects submicroscopic deletions and duplications known as copy‑number variants (CNVs) that are invisible on a standard karyotype, making it essential for diagnosing microdeletion syndromes like 22q11.2 or 16p11.2, autistic spectrum‑related CNVs, and unexplained intellectual disability, while the included karyotype confirms balanced translocations and large aneuploidies.

2. Can this test be performed on cord blood or fetal blood, and what are the requirements?

Yes, the test accepts cord blood or fetal blood samples obtained via cordocentesis under strict aseptic conditions; a consultant obstetrician must provide a clinical justification, and the sample must be transported in a sodium‑heparin tube via our ISO‑certified cold chain to preserve cellular viability for culture. Collection is performed exclusively in hospital settings.

3. How do I arrange for blood collection and will insurance cover the cost?

For this test, sample collection is arranged at an accredited hospital facility – no home phlebotomy is available. Our team will assist in coordinating the appointment. Insurance eligibility can be verified instantly via WhatsApp at +971 54 548 8731; most major policies cover medically indicated genetic testing with a doctor’s prescription.

UAE Regulatory & Data Privacy Adherence

Your Data, Your Control

DNA Labs UAE complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic and clinical data are encrypted, stored in UAE‑based servers with restricted access, and never shared without explicit patient consent. Clinical testing and patient safety follow the provisions of Federal Decree‑Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name Chromosomal Microarray 60K with Karyotyping
Price (AED) 3,000
Turnaround Time 7–9 working days
Sample Type / Matrix Peripheral Blood, Cord Blood, Fetal Blood (sodium‑heparin bottle)
Methodology Used Agilent 60K Microarray + GTG‑banded Karyotyping
ICD‑10‑CM Code Z01.818 (Encounter for other specified special examinations)
LOINC Code 82119-6 (Chromosomal microarray analysis)
DHA Facility License & Laboratory Address License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians